白细胞介素12对肝癌基因治疗的实验研究

目的 研究携带白细胞介素１２（ＩＬ－１２）基因逆转录病毒载体对体内肝癌生长抑制作用,探索基因治疗肝癌新途径。方法 构建携带ＩＬ－１２的逆转录病毒载体,转染逆转录病毒包装细胞系ＰＡ３１７,应用该包装细胞对实验性肝癌大鼠进行治疗,观察抗肿瘤作用,免疫功能变化。     

铝-铬天青-溴化十六烷基啶胶束增溶分光光度法测定血清铝的方法研究

在溶液p H6-5 ～5-5 范围内,铝铬天青S(CAS)溴化十六烷基吡啶(CPB) 生成兰色三元胶束配合物,它的最大吸收在618n m 波长,摩尔吸光系数ε为9-642 ×104L.m ol-1 .c m -1 。在铝含量0 ～6-0 ×10 -6m ol.L- 1,遵循比耳定律,AlCASCPB三元配合物的组成摩尔比是1∶2∶3 。一定量的抗坏血酸和盐酸羟胺可以消除血清中与铝共存的其它阳离子Fe3 ,Cu2 等的干扰。该方法的检出限为6-60 ×10 - 7mol .L-1 ,平均回收率(96-11 ±2-87) % ,相对标准差小于3 % 。方法简便易行,有较高的准确度和灵敏度,用于血清铝的测定可获得满意结果     

下斜肌转位术治疗分离性垂直偏斜

分离性垂直偏斜（简称DVD）亦称上隐斜。该病病因不清,治疗方法亦各不相同,临床较多采用上直肌减弱术。下斜肌止端转位术是KratZ1989年报道的一种新的DVD矫正术。近三年我们采用上直肌后徙术及下斜肌止端转位术治疗DVD,取得较好疗效。现报告如下,l临床资料11对象本组16例,年龄7一月岁,男6例,女10例,合并内斜9例,合并外斜5例,Helveston综合征2例。患者术前均行视力、屈光状态、眼位、注视性质、眼底、三棱镜及同视机检查。1．2手术设计及效果DVD手术定量主要根据第一眼位用交替遮盖试验测量最大斜视程度来决定,一般在Drp影…     

Acute fulminant invasive fungal sinusitis]

OBJECTIVE: To discuss the clinical presentation, diagnostic criterion and treatment principle of acute fulminant invasive fungal rhinosinusitis (AFFS). METHODS: Six patients were diagnosed as AFFS based on history, nose, especially eye symptoms with or without fever, sinus CT and MRI, endoscopic and cytological findings in the nasal cavity. Surgical debridement was performed on 5 of 6 biopsy proven AFFS patients, one of them being amputated of the orbital content. With the original disease controlled simultaneously, 4 of 5 patients were prescribed with systemic amphotericin B or liposomal amphotericin B (1 case) and one with Itraconazole orally. One patient had not been involved with any of the anti-fungi measures. RESULT: Mucor (Zygomycetes) was identified on culture in 1 patient, Rhizopus species in 2, Aspergillus in 1, Alternaria in 1 and mixed Mucor and Rhizopus in 1. All patients were proved of tissue invasion histopathologically through biopsy. One patient died without any anti-fungi therapy on the 7th admission day, 3 patients survived for 88 days, 32 and 6 months respectively and died of original diseases (diabetes 1, leukaemia 2). One patient survived 9 months and lost for follow-up, 1 patient survived 11 months after treatment. CONCLUSION: A high index of suspicion and early endoscopic investigation through nasal cavity with fungal investigation should highly be strengthened for recognition of this disease. MRI findings should be considered as, or even more, important as that of CT scan on the early diagnoses. Extensive and aggressive surgical debridement, prompt and enough dosage of antifungal therapy intravenously, together with serious controlling of the underlying disease, all take important roles in the complete control of the disease.     

Salicylate enhances necrosis and apoptosis mediated by the mitochondrial permeability transition.

Onset of the mitochondrial permeability transition (MPT) causes both necrotic and apoptotic cell death in cultured hepatocytes. Salicylate lowers the threshold for onset of the MPT. In this study, our aim was to determine whether nontoxic concentrations of salicylate potentiate MPT-mediated cell killing. In necrotic killing models to rat hepatocytes, salicylate (1 mM) enhanced calcium ionophore (Br-A23187)- and tert-butylhydroperoxide (t-BuOOH)-induced cell death, which was blocked or delayed by cyclosporin A (CsA, 2 microM), a specific inhibitor of the MPT. In hepatocyte apoptosis induced by tumor necrosis factor-alpha (TNF-alpha), salicylate accelerated cell killing after low-dose TNF-alpha (1 ng/ml), which by itself induced little apoptosis. Salicylate enhancement of apoptosis was associated with onset of the MPT and accelerated caspase 3 activation. Salicylate also augmented killing of MCF-7 human breast tumor cells by etoposide and PLC/PRF/5 human hepatoma cells by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). In conclusion, salicylate potentiates both necrotic and apoptotic cell killing by promoting onset of the MPT. Enhancement by salicylate of MPT-dependent apoptosis may play a role in protection by aspirin and other nonsteroidal anti-inflammatory drugs against colon, lung, and breast cancer.     

宫颈癌患者外周血Th1/Th2细胞因子表达水平的研究

目的 :分析 2 7例宫颈癌患者外周血单个核细胞 (PBMC)中Th1/Th2 两类细胞因子的表达水平 ,并与正常人比较 ,了解宫颈癌患者的免疫漂移现象。方法 :利用RT PCR技术检测 2 7例宫颈癌患者PBMC中Th1/Th2 两类细胞因子的mRNA表达水平。结果 :2 7例宫颈癌中IFN γ、IL 2、IL 4、IL 6和IL 10的表达阳性率依次为2 /2 7、3 /2 7、18/2 7、14 /2 7和 18/2 7。结论 :宫颈癌患者高表达Th2 类细胞因子 ,低表达Th1类细胞因子 ,出现典型的Th2 漂移现象 ,为宫颈癌的生物治疗提供可能。     

检测食管癌标本中PCNA和p16及Ki-67的临床意义

对西京医院进行根治性放疗的食管鳞状细胞癌患者 64例 ,照射剂量DT64～ 70Gy ,进行前瞻性研究 ,对其治疗前活检标本进行SP免疫组化染色 ,计数其阳性细胞数 ,并计算阳性率 ,观察其阳性率与食管癌放疗疗效及预后的关系。结果PCNA阳性率 5 1%～ 67 1% ,中央值 3 2 0 % ,PCNA阳性率 >40 %者较低于此值者预后明显差。p16在低分化癌中较高分化癌阳性表达率低 ,且随着病期的进展阳性表达率降低 ,P <0 0 5 ;Ki 67与近期疗效及预后未见明显差异。初步研究结果提示 ,PCNA阳性率是判断放疗疗效有意义的指标 ,且与p16联合检测对食管鳞癌放疗前恶性程度评定和预后估计有重要意义     

Clinical analysis of 276 cases of non-palpable TO breast cancer

Objective Discussion of diagnosis, treatment and prognosis of non-palpable TO breast cancer. Methods Between 1978 and 1997, 9,980 female patients with operable breast cancer were treated surgically, of which 276 were determined to have TO breast cancer. Most TO breast cancers could be detected promptly with careful examination of presenting symptoms, such as nipple discharge, local thickening of the breast, nipple erosion, nipple retraction and postmenopausal mastalgia, while 12 cases were detected by routine mammography of the contralateral breast. Results All patients were treated surgically and their tissue subjected to histopathological examination. Most cases (73.0%) were noninvasive or early invasive carcinoma. Axillary lymph nodes metastases were found in 7.69% of 234 mastectomy cases. Conclusion The survival rate was significantly increased if the tumor was in an early stage. The 5-, 10-, 15-years survival rates were 98.1%, 94.6% and 90.3%, respectively.     

抗癌作用新靶点及其抑制剂的研究进展

针对靶点分子或某种发生发展机制来设计抗肿瘤药物的研究工作已取得了相当大的成就.这类药物的特异性强,疗效显著,因此,针对这些新靶点进行药物设计可以使抗肿瘤药物的研究产生一次新的革命.本综述旨在讨论目前抗肿瘤药物研究的潜在的新靶点以及它们相应的抑制剂或拮抗剂.     

卵巢上皮性癌155例的治疗与预后

目的：探讨卵巢上皮性癌的治疗与影响预后的因素。方法：对１９７０年１月至１９９２年１２月在我院治疗的１５５例卵巢上皮性癌进行回顾性分析。全部手术切除标本经病理检查诊断并按ＦＩＧＯ分期标准进行分期，４２例行２次手术，４例行３次手术。除６例外，余１４９例均于手术后行化疗，３２例于第２次术后再次行化疗，９例因复发再次化疗。结果：２年、５年、１０年的生存率分别为Ⅰ期９２．４％、８７．０％、７０．６％；Ⅱ期９１．９％、６３．６％、４７．８％；Ⅲ期５９．９％、３８．２％、１９．２％；Ⅳ期２５．０％、２５．０％、０．０％（Ｐ＜０．００１）。６例未化疗者均在术后２年内死亡。结果表明，预后与临床分期、细胞分化、残留癌灶大小有关。５年生存率中，Ⅰ期为８７．０％和Ⅲ期为３８．２％（Ｐ＜０．００１）；Ｇ１的５年生存率为９５．９％，Ｇ３为１１．８％（Ｐ＜０．００１）；无残留癌灶者为９７．６％，残留癌灶＞２ｃｍ者为２１．２％（Ｐ＜０．００１）。结论：在卵巢上皮性癌初次手术时残留癌灶＜２ｃｍ，并于术后尽早开始化疗，可提高生存率。